Mavorixafor

Cat. No.: IBDI-434599

Mavorixafor (AMD-070) is a potent, selective and orally available CXCR4 antagonist, with an IC50 value of 13 nM against CXCR4 125I-SDF binding, and also inhibits the replication of T-tropic HIV-1 (NL4.3 strain) in MT-4 cells and PBMCs with an IC50 of 1 and 9 nM, respectively.

Product Details

Target	CXCR | HIV
Molecular Weight	349.47
Appearance	Solid
Synonyms	AMD-070
SMILES	NCCCCN(CC1=NC2=C(N1)C=CC=C2)[[email protected]@H]3C4=C(CCC3)C=CC=N4

Storage & Handling

Shipping	Room temperature in continental US. May vary elsewhere.
Storage	Please store the product under the recommended conditions in the Certificate of Analysis.
Regulatory Status	This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use.